Cargando…
Twist1 Inactivation in Dmp1-Expressing Cells Increases Bone Mass but Does Not Affect the Anabolic Response to Sclerostin Neutralization
Wnt signaling plays a major role in bone metabolism. Advances in our understanding of secreted regulators of Wnt have yielded several therapeutic targets to stimulate osteoanabolism—the most promising of which is the Wnt inhibitor sclerostin. Sclerostin antibody recently gained approval for clinical...
Autores principales: | Lewis, Karl J., Choi, Roy B-J, Pemberton, Emily Z., Bullock, Whitney A., Firulli, Anthony B., Robling, Alexander G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769567/ https://www.ncbi.nlm.nih.gov/pubmed/31505764 http://dx.doi.org/10.3390/ijms20184427 |
Ejemplares similares
-
COMBINING SCLEROSTIN AND DKK1 INHIBITORS TO IMPROVE BONE PROPERTIES IN THE AGED SKELETON
por: Choi, Roy, et al.
Publicado: (2022) -
Improving Bone Health by Optimizing the Anabolic Action of Wnt Inhibitor Multitargeting
por: Choi, Roy B, et al.
Publicado: (2021) -
Phosphoregulation of Twist1 Provides a Mechanism of Cell Fate Control
por: Firulli, Anthony B, et al.
Publicado: (2008) -
Targeting Sclerostin and Dkk1 at Optimized Proportions of Low-Dose Antibody Achieves Similar Skeletal Benefits to Higher-Dose Sclerostin Targeting in the Mature Adult and Aged Skeleton
por: Choi, Roy B., et al.
Publicado: (2022) -
Lrp4 Mediates Bone Homeostasis and Mechanotransduction through Interaction with Sclerostin In Vivo
por: Bullock, Whitney A., et al.
Publicado: (2019)